Anticoagulation on Demand in Paroxysmal Atrial Fibrillation After Percutaneous Coronary Intervention
Status:
Not yet recruiting
Trial end date:
2021-11-30
Target enrollment:
Participant gender:
Summary
Preliminary experiences suggest that intermittent anticoagulation guided by continuous
electrocardiographic monitoring can reduce the incidence of bleeding in patients with
episodes of atrial fibrillation.
Uncertainty about the potential implications of a strategy of intermittent anticoagulation
after percutaneous coronary intervention exists.
The investigators will perform a pilot randomized trial to evaluate the safety and efficacy
of anticoagulation on demand in patients with paroxysmal atrial fibrillation after
percutaneous coronary intervention.